| Name | Depemokimab |
|---|
| Description | Depemokimab (GSK-3511294) is a long-acting anti-IL-15 monoclonal antibody. Depemokimab can be used for research of asthma[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IL-15[1] |
| In Vivo | Depemokimab (食蟹猴药代动力实验) 与 Mepolizumab (HY-P9945) 相比,清除率降低约 2 倍,IL-5 结合亲和力比 Mepolizumab 高约 30 倍[2]。 |
| References |
| No Any Chemical & Physical Properties |